pyrazines has been researched along with piperazine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Fotsch, C; St Jean, DJ | 1 |
Aparicio, D; Attanasi, OA; de Los Santos, JM; Filippone, P; Ignacio, R; Lillini, S; Mantellini, F; Palacios, F | 1 |
Ahn, JH; Bae, MA; Cheon, HG; Jun, MA; Kang, NS; Kang, SK; Kim, KR; Kim, KY; Kim, SG; Kim, SS; Kim, SY; Lee, DH; Lee, JO; Park, WS; Rhee, SD; Shin, MS; Sohn, SK | 1 |
Cai, J; Ji, M; Zhou, B | 1 |
Bugarin, A; Joshi, SD; Lewis, AM; Noonikara-Poyil, A; Patil, M; Patil, SA | 1 |
Cai, Q; Huang, G; Li, W; Li, Z; Liu, W; Ma, G; Meng, X; Wang, S; Zhang, Y | 1 |
1 review(s) available for pyrazines and piperazine
Article | Year |
---|---|
Mitigating heterocycle metabolism in drug discovery.
Topics: Animals; Biotransformation; Databases, Factual; Drug Discovery; Drug Interactions; Heterocyclic Compounds, 1-Ring; Heterocyclic Compounds, 4 or More Rings; Humans; Mice; Pharmaceutical Preparations; Rats | 2012 |
5 other study(ies) available for pyrazines and piperazine
Article | Year |
---|---|
Straightforward access to pyrazines, piperazinones, and quinoxalines by reactions of 1,2-diaza-1,3-butadienes with 1,2-diamines under solution, solvent-free, or solid-phase conditions.
Topics: Amines; Aza Compounds; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Piperazine; Piperazines; Pyrazines; Quinoxalines; Solutions; Solvents | 2006 |
Synthesis and biological evaluation of homopiperazine derivatives with beta-aminoacyl group as dipeptidyl peptidase IV inhibitors.
Topics: Binding Sites; Chemistry, Pharmaceutical; Crystallography, X-Ray; Cytochrome P-450 CYP3A; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Drug Design; Humans; Inhibitory Concentration 50; Models, Chemical; Molecular Structure; Piperazine; Piperazines; Pyrazines; Sitagliptin Phosphate; Structure-Activity Relationship; Triazoles | 2008 |
Design, synthesis and biological evaluation of bitopic arylpiperazine-hexahydro-pyrazinoquinolines as preferential dopamine D3 receptor ligands.
Topics: Dose-Response Relationship, Drug; Drug Design; HEK293 Cells; Humans; Ligands; Molecular Structure; Piperazine; Pyrazines; Quinolines; Receptors, Dopamine D3; Structure-Activity Relationship | 2018 |
Synthesis, molecular docking studies, and in vitro antimicrobial evaluation of piperazine and triazolo-pyrazine derivatives.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Piperazine; Pyrazines; Structure-Activity Relationship | 2022 |
Increasing brain glucose metabolism by ligustrazine piperazine ameliorates cognitive deficits through PPARĪ³-dependent enhancement of mitophagy in APP/PS1 mice.
Topics: Adenosine Triphosphate; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; Cognition; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Luciferases; Mice; Mice, Transgenic; Mitophagy; Piperazine; PPAR gamma; Presenilin-1; Protein Kinases; Pyrazines; Rats; Sequestosome-1 Protein; Ubiquitin-Protein Ligases | 2022 |